The Development Program. The Development Program shall have a term (the "Development Term") which commences upon the date an R&D Candidate is selected for Development and shall continue until the JSC agrees to cease the Development of the last remaining R&D Candidate or until all Regulatory Approvals for all R&D Candidates have been received in the Territory.
Appears in 2 contracts
Sources: Research and Development (Cambridge Antibody Technology Group PLC), Research, Development and Commercialization Agreement (Cambridge Antibody Technology Group PLC)
The Development Program. The Development Program shall have a term (the "βDevelopment Term"β) which commences upon on the date an R&D Candidate is selected for Development Effective Date and shall continue until the JSC agrees to cease the Development clinical development of the last remaining final R&D Candidate or until all Regulatory Approvals for all R&D Candidates have been received in the Territory.
Appears in 1 contract